PIEZO1 is essential for the survival and proliferation of acute myeloid leukemia cells
Cancer Medicine · 2024
DOI: 10.1002/cam4.6984 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Delphine Lebon und 9 weiteren Autor:innen. Beteiligte Einrichtung: HEMATIM UR4666, Université Picardie Jules Verne, Amiens, France. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ligue Contre le Cancer, JNCL.
Abstract (Originalsprache)
Introduction
Leukemogenesis is a complex process that interconnects tumoral cells with their microenvironment, but the effect of mechanosensing in acute myeloid leukemia (AML) blasts is poorly known. PIEZO1 perceives and transmits the constraints of the environment to human cells by acting as a non‐selective calcium channel, but very little is known about its role in leukemogenesis.
Results
For the first time, we show that PIEZO1 is preferentially expressed in healthy hematopoietic stem and progenitor cells in human hematopoiesis, and globally overexpressed in AML cells. In AML subtypes, PIEZO1 expression associates with favorable outcomes as better overall (OS) and disease‐free survival (DFS). If PIEZO1 is expressed and functional in THP1 leukemic myeloid cell line, its chemical activation doesn’t impact the proliferation, differentiation, nor survival of cells. However, the downregulation of PIEZO1 expression dramatically reduces the proliferation and the survival of THP1 cells. We show that PIEZO1 knock‐down blocks the cell cycle in G0/G1 phases of AML cells, impairs the DNA damage response pathways, and critically increases cell death by triggering extrinsic apoptosis pathways.
Conclusions
Altogether, our results reveal a new role for PIEZO1 mechanosensing in the survival and proliferation of leukemic blasts, which could pave the way for new therapeutic strategies to target AML cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HEMATIM UR4666, Université Picardie Jules Verne, Amiens, France.
- Hématologie Clinique et Thérapie Cellulaire, CHU Amiens-Picardie, Amiens, France.
- Service d'Hématologie Biologie, CHU Amiens-Picardie, Amiens, France.
- Division of Hematology/Oncology Boston Children's Hospital, Boston, Massachusetts, USA.
- Department of Medical and Population Genetics, The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
ORCID-Profile: Delphine Lebon
Förderung
- Ligue Contre le Cancer
- JNCL
Zitieren
APA
Lebon, D., Collet, L., Djordjevic, S., Gomila, C., Ouled-Haddou, H., Platon, J., Demont, Y., Marolleau, J. P., Caulier, A., & Garçon, L. (2024). PIEZO1 is essential for the survival and proliferation of acute myeloid leukemia cells. Cancer Medicine. https://doi.org/10.1002/cam4.6984
Vancouver
Lebon D, Collet L, Djordjevic S, Gomila C, Ouled-Haddou H, Platon J, et al. PIEZO1 is essential for the survival and proliferation of acute myeloid leukemia cells. Cancer Medicine. 2024. doi:10.1002/cam4.6984
BibTeX
@article{Lebon2024,
author = {Lebon, Delphine and Collet, Louison and Djordjevic, Stefan and Gomila, Cathy and Ouled-Haddou, Hakim and Platon, Jessica and Demont, Yohann and Marolleau, Jean-Pierre and Caulier, Alexis and Garçon, Loïc},
title = {PIEZO1 is essential for the survival and proliferation of acute myeloid leukemia cells},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.6984}
}
EUVIMED